IL2 and mastitis: In the current study, we aimed to investigate the activity of cefquinome against clinical mastitis E. coli strains in vitro, and evaluate in vivo therapeutic efficacy of mouse E. coli mastitis by monitoring bacterial colony counts and the cytokine of tumor necrosis factor -α (TNF-α) and interleukin -2 (IL-2).